What is the preferred intravenous antibiotic for cellulitis resulting from a cat bite?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

IV Antibiotic of Choice for Cat Bite Cellulitis

For cellulitis from a cat bite requiring intravenous therapy, ampicillin-sulbactam (1.5-3.0 g every 6-8 hours) is the preferred first-line agent. 1

Rationale for Ampicillin-Sulbactam

The IDSA guidelines consistently recommend ampicillin-sulbactam as a primary IV option for animal bite infections across both their 2005 and 2014 updates 2, 1. This choice is driven by the unique microbiology of cat bites:

  • Pasteurella multocida is isolated in 75% of infected cat bite wounds 2, 3
  • Cat bites yield an average of 5 different aerobic and anaerobic bacteria per wound 2
  • Anaerobes are present in 65% of cat bite infections 2
  • Staphylococci and streptococci occur in approximately 40% of cases 2

Ampicillin-sulbactam provides excellent coverage against P. multocida (the dominant pathogen), anaerobes, streptococci, and methicillin-susceptible staphylococci in a single agent.

Alternative IV Options

If ampicillin-sulbactam is unavailable or contraindicated, the following alternatives are guideline-supported 1:

Second-tier choices:

  • Piperacillin-tazobactam 3.37 g every 6-8 hours
  • Carbapenems (ertapenem 1 g daily, imipenem 1 g every 6-8 hours, or meropenem 1 g every 8 hours)

Combination regimens:

  • Ceftriaxone 1 g every 12 hours PLUS metronidazole 500 mg every 8 hours
  • Doxycycline 100 mg every 12 hours (has excellent activity against P. multocida but some streptococci are resistant) 1

Critical Pitfalls to Avoid

Do NOT use these agents for cat bite cellulitis 2:

  • First-generation cephalosporins (cephalexin, cefazolin) - poor activity against P. multocida
  • Penicillinase-resistant penicillins (dicloxacillin, nafcillin) - miss P. multocida
  • Clindamycin monotherapy - misses P. multocida despite good anaerobic coverage
  • Macrolides (erythromycin) - poor P. multocida activity

All of these agents have inadequate coverage of P. multocida, which is the predominant pathogen in 75% of cat bite infections 3.

When to Consider MRSA Coverage

The standard regimens above do not cover MRSA 1. Add vancomycin 15 mg/kg every 12 hours if:

  • Patient has known MRSA colonization
  • Purulent drainage with gram-positive cocci in clusters on Gram stain
  • Previous MRSA infection
  • Failure to improve on standard therapy

Clinical Context

Cat bites are particularly dangerous because 2, 3:

  • They cause deep puncture wounds with minimal external trauma
  • Infection develops rapidly (often within 3-24 hours) 4
  • They have higher rates of complications than dog bites, including septic arthritis (18%), osteomyelitis, tendonitis, and bacteremia 2, 3
  • Hand wounds are especially high-risk for deep structure involvement 4

Recent case reports confirm that even with appropriate initial therapy, cat bite infections can be severe, requiring surgical debridement and prolonged treatment 5, 6. One study documented complications in 18% of infected cat bites despite treatment 3.

Special Consideration: Francisella tularensis

If the patient fails to improve on standard therapy covering P. multocida, consider Francisella tularensis, which requires different antibiotics (ciprofloxacin or doxycycline) and may relapse after treatment 7. This is increasingly recognized in cat-associated infections and should prompt consultation with local health authorities about regional epidemiology 7.

Duration and Monitoring

  • Typical duration: 7-10 days for uncomplicated cellulitis 2
  • Extend to 3-4 weeks for septic arthritis or tendonitis 2
  • Extend to 4-6 weeks for osteomyelitis 2
  • Transition to oral amoxicillin-clavulanate 875/125 mg twice daily once clinically improving 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.